FeesSafety
Pluang+

US dollar gains as Bitcoin and gold weaken amid global political tensions in October

Market News
03 Nov 2026, 13:58 WIB
Tokenpost
View Source
Neutral
US dollar gains as Bitcoin and gold weaken amid global political tensions in October

In October, the US dollar strengthened as traditional safe-haven assets like Bitcoin and gold declined, despite ongoing political and geopolitical tensions worldwide. Issues such as worsening fiscal conditions in France, political uncertainties in the US and Israel, and conflicts involving Iran and Saudi Arabia contributed to market unease. This shift challenges the idea that investors will move away from the dollar into alternatives like gold and Bitcoin, suggesting the dollar-debasement trade may be ending.

The US dollar's strength in October contrasts with declines in Bitcoin and gold, providing context for market dynamics. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Nov 03, 2026 19:03 WIB: out of 50 major cryptocurrencies priced on Pluang, 12 rose and 37 fell today. Notable movers include CRV (Curve DAO Token) down 5.07% at Rp4.721 with a typical hold time of 62 days and a 60% sell order activity, BAT (Basic Attention Token) down 4.09% at Rp2.296 with a 93-day hold time and 95% buy order activity, and SAND (The Sandbox) down 3.47% at Rp803 with a 124-day hold time and balanced order activity.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
19 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
19 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
19 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App